Loeb's Third Point Exited Amgen (AMGN); Continues to Hold Allergan (AGN), Baxter (BAX)
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $273.54 --0%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.3%
EPS Growth %: -2.3%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.3%
EPS Growth %: -2.3%
Join SI Premium – FREE
Dan Loeb's Third Point LLC sold out of Amgen (NASDAQ: AMGN) in Q2, continued to hold its Allergan (NYSE: AGN) stake and continues to see meaningful upside in Baxter (NYSE: BAX), according to an investors letter.
The firm is also long over $1 billion in energy credit and completed a private investment in Didi in Q2.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- BofA says there is a continued strength in buybacks
- Legacy Credit Reports Over 5% Stake in VCI Global (VCIG)
Create E-mail Alert Related Categories
13Fs, Hedge Funds, Trader TalkRelated Entities
Daniel Loeb, Third Point LLCSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
